Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: Mitomycin versus cisplatin

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2720-2727

  Blackham, Aaron U ^a   Shen, Perry ^a   Stewart, John H ^a   Russell, Gregory B ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MALE; MALIGNANT MESOTHELIOMA; OVERALL SURVIVAL; PERITONEUM MESOTHELIOMA; PROGRESSION FREE SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78049463296     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1080-6     Document Type: Article

References (23)

1. K Sridhar R Doria W Raub R Thurer M Saldana 1992 New strategies are needed in diffuse malignant mesothelioma Cancer. 70 2969 2979 1:STN:280:DyaK3s%2Fot1Knsg%3D%3D 10.1002/1097-0142(19921215)70:12<2969::AID- CNCR2820701239>3.0.CO;2-A 1451080
2. J Wagner C Sleggs P Marchand 1960 Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br J Ind Med. 17 260 271 1:STN:280:DyaF3c7gt1OgsQ%3D%3D 13782506
3. B Robinson R Lake 2005 Advances in Malignant Mesothelioma NEJM. 353 1591 1603 1:CAS:528:DC%2BD2MXhtFWhur7O 10.1056/NEJMra050152 16221782
4. E Chailleux G Dabouis D Pioche M de Lajartre A de Lajartre A Rembeaus, et al. 1988 Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients Chest 93 159 162 1:STN:280:DyaL1c%2FotFOlug%3D%3D 10.1378/chest.93.1.159 3335148
5. H Pass K Kranda B Temeck I Feuerstein S Steinberg 1997 Surgically debulked malignant pleural mesothelioma: results and prognostic factors Ann Surg Oncol. 4 215 222 1:STN:280:DyaK2s3oslaqsg%3D%3D 10.1007/BF02306613 9142382
6. P Janne 2003 Chemotherapy for malignant pleural mesothelioma Clin Lung Cancer. 5 98 106 10.3816/CLC.2003.n.023 14596692
7. K Antman R Shemin L Ryan, et al. 1988 Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985 J Clin Oncol. 6 147 153 1:STN:280:DyaL1c%2FovFOrtg%3D%3D 3335886
8. J Ribak R Lilus Y Suzuki L Penner I Selikoff 1998 Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and cause of death Br J Ind Med. 45 182 187
9. B Loggie R Fleming R MeQuellon G Russell K Geisinger E Levine 2001 Prospective trial for the treatment of malignant peritoneal mesothelioma Am Surg. 67 999 1003 1:STN:280:DC%2BD3MrlslOhsA%3D%3D 11603562
10. B Park H Alexander S Libutti P Wu D Royalty K Kranda D Bartlett 1999 Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion Ann Surg Oncol. 6 582 590 1:STN:280:DyaK1MvitFeksw%3D%3D 10.1007/s10434-999-0582-6 10493628
11. B Loggie R Fleming R McQuellon G Russell K Geisinger 2000 Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin Am Surg. 66 561 568 1:STN:280:DC%2BD3M%2Fhs1ahsg%3D%3D 10888132
12. S Howell C Pfeifle W Wung R Olshen W Lucas J Yon, et al. 1982 Intraperitoneal cisplatin with systemic thiosulfate protection Ann Intern Med. 97 845 851 1:STN:280:DyaL3s%2Fnt12mtw%3D%3D 6890785
13. D Leitao B Blakley 2003 Quantification of sodium thiosulfate protection on cisplatin-induced toxicities J Otolaryngol. 32 146 150 10.2310/7070.2003. 40406 12921131
14. Common Terminology Criteria for Adverse Events (CTCAE). Version 3.0. Published June 10, 2003.
15. M Deraco D Nonaka D Baratti, et al. 2006 Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion Ann Surg Oncol. 13 229 237 10.1245/ASO.2006.03.045 16444562
16. T Yan E Brun C Cerruto N Haveric D Chang P Sugarbaker 2007 Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol. 14 41 49 10.1245/s10434-006-9169-7 17039392
17. D Nonaka S Kusamura D Baratti, et al. 2005 Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated with locoregionally at a single institution Cancer. 104 2181 2188 10.1002/cncr.21239 16206294
18. C Cerruto E Brun D Dhang P Sugarbaker 2006 Prognostic Significance of Histomorphologic parameters in diffuse malignant peritoneal mesothelioma Arch Pathol Lab Med. 130 1654 1661 17076527
19. C Brigand O Monneuse F Mohamed A Sayag-Beaujard S Isaac F Gilly, et al. 2006 Peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study Ann Surg Oncol. 13 405 412 1:STN:280:DC%2BD28%2Fps1Ghtg%3D%3D 10.1245/ASO.2006.05. 041 16485159
20. T Yan L Welch D Black P Sugarbaker 2007 A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol. 18 827 834 1:STN:280:DC%2BD2s3ns1eqsg%3D%3D 10.1093/annonc/mdl428 17130182
21. A Feldman S Libutti J Pingpank, et al. 2003 Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol. 21 4560 4567 1:CAS:528:DC%2BD2cXpsVWqur0%3D 10.1200/JCO.2003.04.150 14673042
22. M Hesdorffer J Chabot M Keohan, et al. 2008 Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma Am J Clin Oncol. 31 49 54 1:CAS:528:DC%2BD1cXivVyqsLk%3D 10.1097/COC.0b013e3180684181 18376228
23. E Levine J Stewart G Russell K Geisinger B Loggie P Shen 2007 Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 patients J Am Coll Surg. 204 943 953 10.1016/j.jamcollsurg.2006.12.048 17481516